Insider adds to position. Gregory T. Lucier purchased 15,000 shares of XRAY at $12.445 per share, according to a Form 4 filing dated March 9, 2026. The transaction totaled $186,675 and increased Lucier’s holdings to 65,000 shares.
Stake more than triples. The purchase represents a 30% increase in Lucier’s position, bringing his total ownership from 50,000 shares to 65,000 shares. The $12.445 price point establishes a clear cost basis for this tranche of his holdings.
Filing provides limited context. The Form 4 does not specify Lucier’s current title or role with XRAY, though his willingness to deploy nearly $187,000 of capital suggests confidence in the company’s near-term prospects. Insider purchases of this magnitude—particularly when they materially expand an existing position—often signal that management sees the current valuation as attractive.
Transaction stands alone. This filing represents a single purchase with no accompanying sales or derivative transactions. The straightforward nature of the trade—an outright share purchase at market price—carries more weight than complex option exercises or pre-planned selling programs.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.
The post DENTSPLY SIRONA (XRAY) Insider Gregory T. Lucier Buys 15,000 Shares at $12.45, Boosting Stake 30% first appeared on Alphastreet.
